Skip to content

Clinical trials

Leiomyoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leiomyoma Country / region: China Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20111
20121
20141
20161
20172
20183
20201
20223
20234
20243
20259
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8
Unknown status8
Completed6
Not yet recruiting5
Active, not recruiting3
Terminated3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jiangsu HengRui Medicine Co., Ltd.3
Wenwen Wang3
Bayer2
Huazhong University of Science and Technology2
Second Affiliated Hospital of Wenzhou Medical University2
West China Second University Hospital2
Bio Genuine (Shanghai) Biotech Co., Ltd.1
Catherin Zhang1
Chang Zhou1
China Resources Zizhu Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leiomyoma34
Adenomyosis4
Endometriosis4
Gastrointestinal Stromal Tumors3
Menorrhagia3
Endometrial Neoplasms2
Myofibroma2
Ovarian Neoplasms2
Uterine Cervical Neoplasms2
Adnexal Diseases1

Trials

Showing 51 to 34 of 34. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.